SCHEMBL6110401

SCHEMBL6110401

CC(C)COC(=O)N1CC=Cc2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX4 Q99571 7/20 0.64
ALDH1A1 P00352 3/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 1/20 0.40
SCN9A Q15858 1/20 0.39
SCN10A Q9Y5Y9 1/20 0.39
P2RX1 P51575 3/20 0.39
P2RX3 P56373 3/20 0.39
P2RX7 Q99572 2/20 0.39
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
PTBP1 P26599 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205655 0.86 SMN1; SMN2 (0.53) P2RX4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL29549990 0.86 SMN1; SMN2 (0.53) P2RX4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL7161164 0.86 P2RX4 (0.48) P2RX4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL6110992 0.82 SMN1; SMN2 (0.44) P2RX4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL8768858 0.82 P2RX4 (0.43) P2RX4SMN1; SMN2LMNAP2RX1P2RX3
SCHEMBL6110761 0.82 P2RX4 (0.46) P2RX4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL8769449 0.80 P2RX4 (0.43) P2RX4SMN1; SMN2LMNAP2RX1P2RX3
SCHEMBL3719677 0.80 BCHE (0.50) P2RX4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL27785934 0.80 P2RX4 (0.58) P2RX4TSHRSMN1; SMN2LMNASCN9A
SCHEMBL28802473 0.80 P2RX4 (0.63) P2RX4ALDH1A1SMN1; SMN2P2RX1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006033004-A1 QUINOLINE COMPOUNDS AS CETP INHIBITORS PFIZER PRODUCTS INC. (US) 2006-03-30 WO disclosed
EP-0819135-A1 SUGAR-MODIFIED CYTOSTATICS BAYER AG (DE) 1998-01-21 EP disclosed
WO-1996031532-A1 SUGAR-MODIFIED CYTOSTATICS BAYER AKTIENGESELLSCHAFT (DE) 1996-10-10 WO disclosed